| Aerosol generating treatments or diagnostics for respiratory or cardiac conditions (acute pulmonary oedema) during the COVID-19 pandemic period
|
SESLHDBR/094 |
|
| Drug and Alcohol - Management of missed consecutive doses: Methadone and buprenorphine/buprenorphine - naloxone
|
SESLHDPR/411 |
|
| Framework for Managing Nursing and Midwifery Staff with Identified Practice Issues
|
SESLHDPD/270 |
|
| Injury Management - Non-Work Related Injury or Illness Management
|
SESLHDPR/564 |
|
| Naltrexone for treatment of long-acting opioid poisoning
|
SESLHDPR/651 |
|
| Name Badges
|
SESLHDPR/233 |
|
| Neonatal Observations for Subgaleal Haemorrhage following vaginal application of vacuum or forceps
|
SESLHDPR/414 |
|
| Neonatal Services Demand Management and Escalation Policy
|
SESLHDPD/304 |
|
| Network Security Policy
|
SESLHDPD/313 |
|
| New or altered interventional procedures, technologies or treatments – safe introduction into clinical practice
|
SESLHDPD/286 |
|
| Noise management handbook
|
SESLHDHB/015 |
Under Review |
| Norfolk Island Health and Residential Aged Care Service (NIHRACS) and South Eastern Sydney Local Health District Complex Patient Transfer Pathway
|
SESLHDPR/596 |
|
| Notification of Death for non-inpatients
|
SESLHDPR/216 |
|
| Nursing and Midwifery Registration
|
SESLHDPD/030 |
|
| Nursing Observation for Total and Completion Thyroidectomy
|
SESLHDGL/046 |
|
| Smoking Cessation: Nurse/Midwife Initiated Nicotine Replacement Therapy (NRT)
|
SESLHDPR/494 |
|
| Take-home naloxone under the Opioid Overdose Response and Take Home Naloxone (ORTHN) intervention (Nyxoid® or Prenoxad®)
|
SESLHDPR/658 |
|
| Work Health and Safety - Health and Safety Representatives Nomination and Election Guideline
|
SESLHDGL/020 |
|
| Work Health and Safety - Noise Management Procedure
|
SESLHDPR/394 |
|
